✦ LIBER ✦

Clinical Development of Temsirolimus, a Novel mTOR Inhibitor, for Treatment of Advanced Malignancies

✍ Scribed by Janet E. Dancey

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Study of Temsirolimus (CCI-779)

✍ Chan, S. 📂 Article 📅 2005 🏛 American Society of Clinical Oncology 🌐 English ⚖ 163 KB

Clinical development of novel proteasome

✍ Yang, Huanjie; Zonder, Jeffrey A; Dou, Q Ping 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 609 KB

Farnesyltransferase inhibitors: Novel co

✍ Jorge E Cortes; Razelle Kurzrock; Hagop M Kantarjian 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Bortezomib, a novel proteasome inhibitor

✍ Graham Jackson; Hermann Einsele; Phillippe Moreau; Jesus San Miguel 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Clinical development of GDC-0449, a hedg

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

A phase I study of weekly temsirolimus a

✍ Sarah M. Temkin; S. Diane Yamada; Gini F. Fleming 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 317 KB